Safety and Feasibility of Lung Resection after Immunotherapy for Metastatic or Unresectable Tumors

BACKGROUND: Surgeons are increasingly asked to operate on patients with residual disease after immunotherapy. The safety and utility of lung resection in this setting are unknown. METHODS: We performed a retrospective review of patients who underwent lung resection within 6 months of treatment with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Thorac Surg
Main Authors: Bott, Matthew J., Cools-Lartigue, Jonathan, Tan, Kay See, Dycoco, Joseph, Bains, Manjit S., Downey, Robert J., Huang, James, Isbell, James M., Molena, Daniela, Park, Bernard J., Rusch, Valerie W., Sihag, Smita, Jones, David R., Adusumilli, Prasad S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357770/
https://ncbi.nlm.nih.gov/pubmed/29550207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2018.02.030
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados